Evidence map›Paper›PMID 36768696›Full record

ArticleInternational journal of molecular sciences2023

Comparative Analysis of Library Preparation Approaches for SARS-CoV-2 Genome Sequencing on the Illumina MiSeq Platform.

Anna Gladkikh, Ekaterina Klyuchnikova, Polina Pavlova, Valeriya Sbarzaglia, Nadezhda Tsyganova, Margarita Popova, Tatiana Arbuzova, Alena Sharova, Edward Ramsay, Andrei Samoilov and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna GladkikhSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.ORCID 0000-0001-6759-1907
Ekaterina KlyuchnikovaSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.
Polina PavlovaSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.
Valeriya SbarzagliaSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.
Nadezhda TsyganovaSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.
Margarita PopovaSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.
Tatiana ArbuzovaSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.
Alena SharovaSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.
Edward RamsaySaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.
Andrei SamoilovSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.ORCID 0000-0001-8284-3164
Vladimir DedkovSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.ORCID 0000-0002-5500-0169
Areg TotolianSaint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for over two years of the COVID-19 pandemic and a global health emergency. Genomic surveillance plays a key role in overcoming the ongoing COVID-19 pandemic despite its relative successive waves and the continuous emergence of new variants. Many technological approaches are currently applied for the whole genome sequencing (WGS) of SARS-CoV-2. They differ in key stages of the process, and they feature some differences in genomic coverage, sequencing depth, and in the accuracy of variant-calling options. In this study, three different protocols for SARS-CoV-2 WGS library construction are compared: an amplicon-based protocol with a commercial primer panel; an amplicon-based protocol with a custom panel; and a hybridization capture protocol. Specific differences in sequencing depth and genomic coverage as well as differences in SNP number were found. The custom panel showed suitable results and a predictable output applicable for the epidemiological surveillance of SARS-CoV-2 variants.

Indexed as

COVID-19SARS-CoV-2Gene LibraryGenome, ViralHumansPandemicsamplicon-based sequencing approachCOVID-19genomic coveragehybridization capture sequencing approachSARS-CoV-2SNP

Identifiers

PMID36768696
PMCPMC9916928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.